Trulieve Cannabis Subordinate Voting Shares Quarterly Income Statement
NYSE: TRLVHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Trulieve Cannabis Subordinate Voting Shares revenue and earnings
In the quarter ended Jun 30, 2026, Trulieve Cannabis Subordinate Voting Shares generated $271.0 million in revenue, down 10.3% from the same quarter a year earlier. Trulieve Cannabis Subordinate Voting Shares reported a net loss of $406.1 million, compared with a loss of $16.1 million a year earlier. Gross margin was 59.9% (down from 60.6%) and operating margin -136.7%.
Diluted earnings per share came in at -$2.10.
Summary generated from market data by MetaCap's automated system. Methodology
Trulieve Cannabis Subordinate Voting Shares income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 270.95M | 286.75M | 293.15M | 288.19M | 302.09M | 297.76M | 301.14M | 284.28M | 303.44M | 297.62M | 286.97M | 275.21M |
| Revenue growth (YoY) | -10.31% | -3.70% | -2.66% | +1.37% | -0.45% | +0.05% | +4.94% | +3.30% | +7.68% | +4.35% | -3.85% | -6.82% |
| Cost of Revenue | 108.66M | 116.67M | 117.98M | 118.33M | 119.16M | 114.54M | 114.13M | 111.01M | 121.79M | 123.82M | 133.12M | 132.26M |
| Gross Profit | 162.29M | 170.08M | 175.16M | 169.86M | 182.93M | 183.22M | 187.02M | 173.28M | 181.65M | 173.80M | 153.85M | 142.95M |
| Operating Expenses | 532.81M | 134.36M | 159.87M | 127.62M | 130.29M | 149.89M | 185.71M | 172.66M | 131.89M | 127.70M | 124.67M | 119.60M |
| Selling, General & Admin | 101.77M | 104.89M | 126.31M | 99.02M | 101.12M | 118.77M | 157.94M | 148.62M | 102.58M | 101.31M | 96.29M | 93.85M |
| Operating Income | -370.52M | 35.73M | 15.30M | 42.24M | 52.63M | 33.33M | 1.31M | 618.00K | 49.75M | 46.10M | 29.18M | 23.34M |
| Interest Expense | 12.76M | 13.32M | 14.68M | 16.09M | 16.39M | 16.30M | 14.62M | 17.46M | 15.45M | 14.67M | 20.64M | 20.83M |
| Other Income (Expense) | -12.87M | -10.51M | -12.36M | -12.94M | -13.73M | -13.00M | -14.21M | -13.46M | -13.25M | -14.15M | -20.36M | -9.62M |
| Pretax Income | -383.40M | 25.22M | 2.94M | 29.30M | 38.90M | 20.33M | -12.90M | -12.84M | 36.51M | 31.95M | 8.82M | 13.72M |
| Income Tax | 21.97M | 21.86M | 47.89M | 53.04M | 54.72M | 52.46M | 47.57M | 47.38M | 47.20M | 55.44M | 45.42M | 36.64M |
| Net Income | -406.06M | 2.28M | -43.59M | -28.78M | -16.11M | -33.76M | -61.56M | -61.60M | -11.98M | -24.52M | -34.79M | -25.84M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -2.10 | 0.02 | -0.24 | -0.11 | -0.07 | -0.16 | -0.27 | -0.32 | -0.04 | -0.16 | -0.18 | -0.12 |
| EPS (Diluted) | -2.10 | 0.02 | -0.24 | -0.11 | -0.07 | -0.16 | -0.27 | -0.32 | -0.04 | -0.16 | -0.18 | -0.12 |
| Shares Outstanding (Basic) | 192.71M | 192.54M | — | 191.28M | 191.20M | 191.13M | — | 190.19M | 190.33M | 189.49M | — | 188.92M |
| Shares Outstanding (Diluted) | 192.71M | 197.76M | — | 191.28M | 191.20M | 191.13M | — | 190.19M | 190.33M | 189.49M | — | 188.92M |
| EBITDA | -344.80M | 65.47M | 44.72M | 71.69M | 82.06M | 62.65M | 29.95M | 28.95M | 77.83M | 73.86M | 56.38M | 50.30M |
| Gross Margin | 59.90% | 59.31% | 59.75% | 58.94% | 60.55% | 61.53% | 62.10% | 60.95% | 59.86% | 58.40% | 53.61% | 51.94% |
| Operating Margin | -136.75% | 12.46% | 5.22% | 14.66% | 17.42% | 11.19% | 43.00% | 22.00% | 16.40% | 15.49% | 10.17% | 8.48% |
| Net Margin | -149.86% | 80.00% | -14.87% | -9.99% | -5.33% | -11.34% | -20.44% | -21.67% | -3.95% | -8.24% | -12.12% | -9.39% |
This table shows 12 quarterly periods of Trulieve Cannabis Subordinate Voting Shares's income statement, from Q2 2026 back to Q3 2023, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow TRLV's reporting calendar. What is a income statement?